|
|
||||||||
Receptor 1 Following TCR Engagement1


*
Department of Molecular Genetics and Microbiology, Robert Wood Johnson Medical School-University of Medicine and Dentistry of New Jersey, Piscataway, NJ 08854; and
Department of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA 94305
Activated T lymphocytes modulate the level of many molecules on
their cell surface, including cytokine receptors. This regulation of
cytokine receptor expression affects the ability of T cells to respond
to cytokines and thus influences the outcome of an immune response. The
receptor for IFN-
, a proinflammatory cytokine, consists of two
copies of a ligand binding chain (IFN-
R1) as well as two copies of a
second chain (IFN-
R2) required for signal transduction. The
expression of IFN-
R2 is down-regulated at the mRNA level on
CD4+ T cells when they differentiate into the Th1, but not
the Th2, phenotype. This down-regulation has been demonstrated to
depend on the ligand, IFN-
, which is produced by Th1 but not Th2 T
cells. The regulation of the cell-surface expression of IFN-
receptors during primary T cell activation has not been reported. Naive
and differentiated T lymphocytes express IFN-
R1 at the mRNA level
and as a cell-surface protein. In this study, we present evidence that
cell-surface expression of IFN-
R1 is transiently down-regulated on
the surface of naive CD4+ T cells shortly after TCR
engagement. Furthermore, this down-regulation is not mediated by the
ligand, IFN-
, but results from TCR engagement and can be inhibited
by cyclosporin A.
This article has been cited by other articles:
![]() |
S. J. Turner, E. Olivas, A. Gutierrez, G. Diaz, and P. C. Doherty Disregulated Influenza A Virus-Specific CD8+ T Cell Homeostasis in the Absence of IFN-{gamma} Signaling J. Immunol., June 15, 2007; 178(12): 7616 - 7622. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Haring, V. P. Badovinac, M. R. Olson, S. M. Varga, and J. T. Harty In Vivo Generation of Pathogen-Specific Th1 Cells in the Absence of the IFN-{gamma} Receptor J. Immunol., September 1, 2005; 175(5): 3117 - 3122. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Haring, G. A. Corbin, and J. T. Harty Dynamic Regulation of IFN-{gamma} Signaling in Antigen-Specific CD8+ T Cells Responding to Infection J. Immunol., June 1, 2005; 174(11): 6791 - 6802. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Whitmire, J. T. Tan, and J. L. Whitton Interferon-{gamma} acts directly on CD8+ T cells to increase their abundance during virus infection J. Exp. Med., April 4, 2005; 201(7): 1053 - 1059. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Bernabei, M. Bosticardo, G. Losana, G. Regis, F. Di Paola, S. De Angelis, M. Giovarelli, and F. Novelli IGF-1 down-regulates IFN-{gamma}R2 chain surface expression and desensitizes IFN-{gamma}/STAT-1 signaling in human T lymphocytes Blood, October 15, 2003; 102(8): 2933 - 2939. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Refaeli, L. Van Parijs, S. I. Alexander, and A. K. Abbas Interferon {gamma} Is Required for Activation-induced Death of T Lymphocytes J. Exp. Med., October 7, 2002; 196(7): 999 - 1005. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |